Adjuvant Ovarian Suppression in Premenopausal Breast Cancer | Zendy

Prudence A. Francis | Zendy; Meredith M. Regan | Zendy; Gini F. Fleming | Zendy; István Láng | Zendy; Eva Ciruelos | Zendy; Meritxell Bellet | Zendy; Hervé Bonnefoi | Zendy; Miguel Ángel Climent | Zendy; Gian Antonio Da Prada | Zendy; Harold J. Burstein | Zendy; Silvana Martino | Zendy; Nancy E. Davidson | Zendy; Charles E. Geyer | Zendy; Barbara Walley | Zendy; Robert E. Coleman | Zendy; Pierre Kerbrat | Zendy; Stefan Buchholz | Zendy; James N. Ingle | Zendy; Eric P. Winer | Zendy; Manuela Rabaglio | Zendy; Rudolf Maibach | Zendy; Barbara Ruepp | Zendy; Anita GiobbieHurder | Zendy; Karen N. Price | Zendy; Marco Colleoni | Zendy; Giuseppe Viale | Zendy; Alan S. Coates | Zendy; Aron Goldhirsch | Zendy; Richard D. Gelber | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Author(s) -

Prudence A. Francis,

Meredith M. Regan,

Gini F. Fleming,

István Láng,

Eva Ciruelos,

Meritxell Bellet,

Hervé Bonnefoi,

Miguel Ángel Climent,

Gian Antonio Da Prada,

Harold J. Burstein,

Silvana Martino,

Nancy E. Davidson,

Charles E. Geyer,

Barbara Walley,

Robert E. Coleman,

Pierre Kerbrat,

Stefan Buchholz,

James N. Ingle,

Eric P. Winer,

Manuela Rabaglio,

Rudolf Maibach,

Barbara Ruepp,

Anita GiobbieHurder,

Karen N. Price,

Marco Colleoni,

Giuseppe Viale,

Alan S. Coates,

Aron Goldhirsch,

Richard D. Gelber

Publication year - 2014

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1412379

Subject(s) - tamoxifen , breast cancer , medicine , adjuvant , oncology , estrogen , ovarian cancer , antiestrogen , estrogen receptor , cancer , hormone , gynecology

Suppression of ovarian estrogen production reduces the recurrence of hormone-receptor-positive early breast cancer in premenopausal women, but its value when added to tamoxifen is uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research